Zhengye Biotechnology Holding (ZYBT) Shares Outstanding (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Shares Outstanding (Entity) of $47.4 million for Q4 2025, up 3.78% year-over-year from $45.7 million in Q4 2024, and little changed quarter-over-quarter from $47.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Shares Outstanding (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Shares Outstanding (Entity) for 3 consecutive years, with $47.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 3.78% year-over-year to $47.4 million; the TTM figure through Dec 2025 stood at $47.4 million (up 3.78% YoY), while the FY2025 annual figure was $47.4 million, up 3.78% from the prior year.
- Shares Outstanding (Entity) held at $47.4 million in Q4 2025 per ZYBT's latest filing, from $47.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $47.4 million in Q2 2025 and bottomed at $45.7 million in Q4 2023.
- Historically, Shares Outstanding (Entity) has averaged $46.5 million across 3 years, with a median of $46.5 million in 2023.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) changed 0.0% — and 2025, when it gained 3.78%.
- Zhengye Biotechnology Holding's Shares Outstanding (Entity) stood at $45.7 million in 2023, then changed by 0.0% to $45.7 million in 2024, then increased by 3.78% to $47.4 million in 2025.
- Business Quant data shows ZYBT's Shares Outstanding (Entity) at $47.4 million in Q4 2025, $47.4 million in Q2 2025, and $45.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Zhengye Biotechnology Holding | 87.12 Mn | 79.81 Mn | - | 47.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47.35 Mn |
| Jun 30, 2025 | 47.32 Mn |
| Dec 31, 2024 | 45.67 Mn |
| Dec 31, 2023 | 45.67 Mn |